Assembly Biosciences Executive Compensation Details
Ticker: ASMB · Form: DEF 14A · Filed: Apr 23, 2025 · CIK: 1426800
| Field | Detail |
|---|---|
| Company | Assembly Biosciences, INC. (ASMB) |
| Form Type | DEF 14A |
| Filed Date | Apr 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, equity-awards, sec-filing
TL;DR
Assembly Bio exec comp details out: check out Nicole White, Bill Delaney, Jason Okazaki's equity awards for 2024.
AI Summary
Assembly Biosciences, Inc. filed a DEF 14A on April 23, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted to key personnel such as Nicole S. White, William E. Delaney IV, and Jason A. Okazaki, with specific dates of grant and valuation data for outstanding and unvested awards.
Why It Matters
This filing provides transparency into how Assembly Biosciences compensates its top executives, which can influence investor decisions and perceptions of company management.
Risk Assessment
Risk Level: low — This is a routine filing related to executive compensation and does not inherently present new financial risks.
Key Players & Entities
- Assembly Biosciences, Inc. (company) — Filer
- Nicole S. White (person) — Executive
- William E. Delaney IV (person) — Executive
- Jason A. Okazaki (person) — Executive
- 2024-12-31 (date) — Fiscal Year End
- 20250423 (date) — Filing Date
FAQ
What was the fiscal year end for Assembly Biosciences, Inc. covered by this filing?
The fiscal year end covered by this filing was December 31, 2024.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted on April 23, 2025.
Who are some of the key individuals whose compensation is detailed in this filing?
Key individuals mentioned include Nicole S. White, William E. Delaney IV, and Jason A. Okazaki.
What type of compensation information is being disclosed?
The filing details information related to equity awards, including year-end fair value of awards granted, outstanding and unvested awards, and changes in fair value.
What is the SIC code for Assembly Biosciences, Inc.?
The Standard Industrial Classification (SIC) code for Assembly Biosciences, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 23, 2025 by Nicole S. White regarding ASSEMBLY BIOSCIENCES, INC. (ASMB).